These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23951449)

  • 1. Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment.
    Compston JE
    Bonekey Rep; 2012; 1():47. PubMed ID: 23951449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study.
    Vedi S; Ninkovic M; Garrahan NJ; Alexander GJ; Compston JE
    Transpl Int; 2002 Jun; 15(6):290-5. PubMed ID: 12072899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technique, Safety, and Yield of Bone Biopsies for Histomorphometry in Children.
    Mubarak WM; Pastor C; Gnannt R; Parra DA; Amaral JG; Temple MJ; Sochett EB; Connolly BL
    J Vasc Interv Radiol; 2017 Nov; 28(11):1577-1583. PubMed ID: 28827015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
    Arlot M; Meunier PJ; Boivin G; Haddock L; Tamayo J; Correa-Rotter R; Jasqui S; Donley DW; Dalsky GP; Martin JS; Eriksen EF
    J Bone Miner Res; 2005 Jul; 20(7):1244-53. PubMed ID: 15940379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects.
    Kimmel DB; Recker RR; Gallagher JC; Vaswani AS; Aloia JF
    Bone Miner; 1990 Nov; 11(2):217-35. PubMed ID: 2268749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.
    Dempster DW; Zhou H; Recker RR; Brown JP; Bolognese MA; Recknor CP; Kendler DL; Lewiecki EM; Hanley DA; Rao DS; Miller PD; Woodson GC; Lindsay R; Binkley N; Wan X; Ruff VA; Janos B; Taylor KA
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2799-808. PubMed ID: 22701017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
    Feichtinger X; Muschitz C; Heimel P; Baierl A; Fahrleitner-Pammer A; Redl H; Resch H; Geiger E; Skalicky S; Dormann R; Plachel F; Pietschmann P; Grillari J; Hackl M; Kocijan R
    Sci Rep; 2018 Mar; 8(1):4867. PubMed ID: 29559644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
    Dalle Carbonare L; Bertoldo F; Lo Cascio V
    Reumatismo; 2009; 61(1):54-64. PubMed ID: 19370189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial.
    Chavassieux P; Portero-Muzy N; Roux JP; Horlait S; Dempster DW; Wang A; Wagman RB; Chapurlat R
    J Bone Miner Res; 2019 Apr; 34(4):626-631. PubMed ID: 30601581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD; McCarthy EF
    Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
    Cremers S; Garnero P
    Drugs; 2006; 66(16):2031-58. PubMed ID: 17112299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
    Reeve J; Arlot M; Price TR; Edouard C; Hesp R; Hulme P; Ashby JP; Zanelli JM; Green JR; Tellez M
    Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: The ACTIVE phase 3 trial.
    Moreira CA; Fitzpatrick LA; Wang Y; Recker RR
    Bone; 2017 Apr; 97():314-319. PubMed ID: 27826127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.
    Borah B; Ritman EL; Dufresne TE; Jorgensen SM; Liu S; Sacha J; Phipps RJ; Turner RT
    Bone; 2005 Jul; 37(1):1-9. PubMed ID: 15894527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in modern bone histomorphometry.
    Recker RR; Kimmel DB; Dempster D; Weinstein RS; Wronski TJ; Burr DB
    Bone; 2011 Nov; 49(5):955-64. PubMed ID: 21810491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
    Reeve J; Bradbeer JN; Arlot M; Davies UM; Green JR; Hampton L; Edouard C; Hesp R; Hulme P; Ashby JP
    Osteoporos Int; 1991 Jun; 1(3):162-70. PubMed ID: 1790404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.